
Patrick Hopkinson has joined Bristol-Myers Squibb as director of market access and external affairs in the UK. He joins the …
AstraZeneca has agreed a deal with charity Cancer Research UK to develop a first-in-class cancer treatment. AZD-3965 targets the monocarboxylate …
Sanofi-Aventis is readying communications support for two cancer drugs in its portfolio. The pharma company has handed UK communications for …
A manufacturing plant in Ireland is the latest to face staff cuts in the wake of Merck & Co’s merger …
French biotech company Transgene has acquired rights to commercialise a novel cancer vaccine that is being tested against multiple types …

Novo Nordisk is on track to receive NICE approval for its type II diabetes drug Victoza, but will still have …
Beaconsfield, UK-based healthcare communications agency Adventis Health has added two more recruits to its multi-disciplinary teams. Dan Blomfield (pictured left), …

GlaxoSmithKline has handed Swiss contract manufacturer Lonza a contract to produce clinical trial batches of five monoclonal antibodies that are …
A European initiative aimed at fostering new medical research is neglecting its public partners in favour of its private ones, …
The number of animals used in scientific experiments will be reduced under new EU legislation agreed by the European Parliament …
Protalix BioTherapeutics has appointed Tzvi Palash to the newly-created position of chief operating officer. He will be responsible for overseeing …
Johnson & Johnson’s disagreement with Merck over rights to two arthritis drugs is set to come to a head in …
InVentiv Health is to acquire Star Terre Santé, a leading group of healthcare marketing and communications agencies based in Paris. …
Pharma execs are more confident about the sector’s outlook than they were at the start of the year. A survey …
The Greek government has released a list of over 4,000 drugs on which it will impose heavy price cuts. This …

Bristol-Myers Squibb is to acquire biopharma company ZymoGenetics for $885 million to add to its ‘string of pearls’of small biotech …
Judith Teall has been appointed director of patient recruitment at clinical trial technology company Exco InTouch. She has spent more …

How did you find your way into your most current role? I’ve been at Napp for four years now having …
Primary care trust managers should not have a legal right to transfer to similar roles in GP commissioning groups, according …
Pfizer has dropped its experimental brain cancer vaccine rindopepimut, handing back worldwide rights to Celldex Therapeutics from November. Rindopepimut targets …